Palouse Capital Management’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-11,068
| Closed | -$96K | – | 79 |
|
2020
Q1 | $96K | Sell |
11,068
-2,243
| -17% | -$19.5K | 0.06% | 71 |
|
2019
Q4 | $151K | Sell |
13,311
-5,060
| -28% | -$57.4K | 0.06% | 85 |
|
2019
Q3 | $200K | Sell |
18,371
-825
| -4% | -$8.98K | 0.07% | 101 |
|
2019
Q2 | $180K | Hold |
19,196
| – | – | 0.06% | 97 |
|
2019
Q1 | $236K | Buy |
19,196
+786
| +4% | +$9.66K | 0.09% | 86 |
|
2018
Q4 | $218K | Hold |
18,410
| – | – | 0.09% | 85 |
|
2018
Q3 | $265K | Buy |
18,410
+809
| +5% | +$11.6K | 0.09% | 86 |
|
2018
Q2 | $262K | Buy |
17,601
+1,107
| +7% | +$16.5K | 0.09% | 87 |
|
2018
Q1 | $215K | Hold |
16,494
| – | – | 0.07% | 97 |
|
2017
Q4 | $208K | Sell |
16,494
-1,166
| -7% | -$14.7K | 0.07% | 96 |
|
2017
Q3 | $229K | Buy |
17,660
+333
| +2% | +$4.32K | 0.08% | 94 |
|
2017
Q2 | $257K | Sell |
17,327
-1,391
| -7% | -$20.6K | 0.09% | 81 |
|
2017
Q1 | $225K | Buy |
18,718
+4,495
| +32% | +$54K | 0.09% | 89 |
|
2016
Q4 | $196K | Sell |
14,223
-233
| -2% | -$3.21K | 0.08% | 96 |
|
2016
Q3 | $194K | Sell |
14,456
-140
| -1% | -$1.88K | 0.08% | 90 |
|
2016
Q2 | $157K | Sell |
14,596
-390
| -3% | -$4.2K | 0.06% | 92 |
|
2016
Q1 | $157K | Sell |
14,986
-1,066
| -7% | -$11.2K | 0.06% | 94 |
|
2015
Q4 | $190K | Sell |
16,052
-1,500
| -9% | -$17.8K | 0.07% | 107 |
|
2015
Q3 | $205K | Sell |
17,552
-1,124
| -6% | -$13.1K | 0.08% | 106 |
|
2015
Q2 | $269K | Sell |
18,676
-803
| -4% | -$11.6K | 0.09% | 102 |
|
2015
Q1 | $272K | Sell |
19,479
-1,016
| -5% | -$14.2K | 0.1% | 103 |
|
2014
Q4 | $283K | Hold |
20,495
| – | – | 0.1% | 117 |
|
2014
Q3 | $251K | Hold |
20,495
| – | – | 0.1% | 116 |
|
2014
Q2 | $256K | Sell |
20,495
-605
| -3% | -$7.56K | 0.09% | 114 |
|
2014
Q1 | $235K | Sell |
21,100
-1,840
| -8% | -$20.5K | 0.09% | 117 |
|
2013
Q4 | $278K | Sell |
22,940
-375
| -2% | -$4.54K | 0.11% | 110 |
|
2013
Q3 | $284K | Buy |
23,315
+75
| +0.3% | +$914 | 0.11% | 104 |
|
2013
Q2 | $307K | Buy |
+23,240
| New | +$307K | 0.13% | 88 |
|